Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDialight Regulatory News (DIA)

Share Price Information for Dialight (DIA)

Share Price is delayed by 15 minutes
Get Live Data
381.00    8.00 (2.14%)
Bid:
379.00
Ask:
400.00
Spread: 21.00 (5.541%)
Market Cap: £152.30m
DIA Live PriceLast checked at - London Stock Exchange

Intraday Dialight Share Chart

Trading Statement

28 Jan 2025 07:00

RNS Number : 8663U
Dialight PLC
28 January 2025
 

FOR IMMEDIATE RELEASE

 

Dialight PLC

28 January 2025

 

Dialight plc ("Dialight" or the "Company")

Q3 trading update

&

Sanmina litigation - settlement discussions

 

Q3 trading update

Trading performance for the 3-month period ended 31 December 2024 was slightly ahead of our expectations. The business traded profitably and generated positive operating cash flow. Group net debt (excluding leases) at 31 December 2024 was $14.8m (30 September 2024: $15.4m). The Board remains confident that further progress will be made during the rest of the financial year.

 

The early Transformation Plan progress reported with the Interim Results in November continued to gain momentum in the third quarter which has allowed us to introduce our 5th Transformation Pillar of creating a platform for future growth. This will provide a strategy and innovation platform for future products and services that, together with the other four pillars, will provide a solid sales and operational base for future, profitable growth. We will also continue to explore opportunities to accelerate our Transformation Plan to focus on delivering our medium-term ambitions.

 

Sanmina litigation - settlement discussions

On 25 September 2024, Dialight announced the details of the jury verdict in the trial relating to the litigation with its former manufacturing partner, Sanmina Corporation (NASDAQ: SANM) (Sanmina) and confirmed that a definitive judgment would be handed down once certain post-trial motions had been filed. Those post-trial motions have now been filed.

 

The Company is pleased to announce that, following constructive discussions with Sanmina, agreement has now been reached in principle to resolve the dispute. Under the settlement terms, Dialight will pay Sanmina $12m in full and final settlement of all claims between the parties. This amount will be paid in instalments, with the first payment of $4m due by 31 March 2025, followed by 8 instalments (the Deferred Instalments) of $1m paid at the end of each subsequent calendar quarter through to 31 March 2027.

 

The amount of any outstanding Deferred Instalments will be automatically increased from $1m to $1.5m if Dialight's market capitalisation exceeds £100m for 30 consecutive days, subject to total cumulative instalment payments not exceeding $8m. A letter has been filed with the New York Southern District court requesting that judgment is deferred pending agreement on a final definitive settlement and the parties will work together to agree a final definitive settlement agreement.

 

The Board is confident that the initial payment of $4m and the Deferred Instalments totalling $8m will be met from the operational cashflow of the business and that the Group has sufficient headroom to meet its ongoing business needs. In the highly remote event of payment default under the settlement agreement following the initial payment, Sanmina will be entitled to enforce the full judgment (less payments already made) in the ordinary course following a 90-day cure period (1).

 

Steve Blair, Dialight CEO, commented: "I am pleased that we have been able to reach a settlement that allows us to put this long running issue behind us. I would particularly like to thank Jure Sola and Jon Faust of Sanmina for their openness and willingness to agree the settlement. Our focus remains on our Transformation Plan for Dialight, for the benefit of all our stakeholders."

 

Note 1: The full judgment, equating to the total claims by Sanmina (as previously disclosed), would amount to $22.9m comprising the jury award of $8.6m, interest of $6.3m and legal costs of $7m.

 

Contacts: 

 

Dialight plc

Tel: +44 (0)203 058 3542

Steve Blair, CEO

Mark Fryer, CFO

 

Investec Bank plc (Financial Adviser and Corporate Broker)

Tel: +44 (0)207 597 5970

Christopher Baird / James Rudd

 

 

Dialight plc

 

About Dialight:

Dialight (LSE: DIA.L) is a global leader in sustainable LED lighting for industrial applications. Dialight's LED products are providing the next generation of lighting solutions that deliver reduced energy consumption and create a safer working environment. Our products are specifically designed to provide superior operational performance, reliability and durability, reducing energy consumption and ongoing maintenance and achieving a rapid return on investment. The company is headquartered in the UK with operations in Australia, Dubai, Germany, Malaysia, Mexico, Singapore, the UK and the USA. www.dialight.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTEAFFXALNSEAA
Date   Source Headline
5th Apr 202211:34 amRNSAnnual Financial Report
29th Mar 20224:38 pmRNSDirector/PDMR Shareholding
28th Mar 202210:09 amRNSHolding(s) in Company
28th Mar 20227:00 amRNSFinal Results
18th Mar 20222:23 pmRNSHolding(s) in Company
14th Feb 20224:42 pmRNSSecond Price Monitoring Extn
14th Feb 20224:36 pmRNSPrice Monitoring Extension
14th Feb 20227:52 amRNSBlock Listing Application
1st Feb 202210:40 amRNSHolding(s) in Company
19th Jan 20227:00 amRNSDirectorate Change
22nd Nov 20217:00 amRNSTrading Statement
21st Oct 202111:13 amRNSBlock listing Interim Review
21st Oct 202110:38 amRNSDirector/PDMR Shareholding
28th Sep 20214:41 pmRNSSecond Price Monitoring Extn
28th Sep 20214:37 pmRNSPrice Monitoring Extension
23rd Sep 20213:14 pmRNSHolding(s) in Company
23rd Sep 20213:04 pmRNSHolding(s) in Company
23rd Sep 20211:51 pmRNSHolding(s) in Company
23rd Sep 20211:46 pmRNSHolding(s) in Company
20th Sep 20214:36 pmRNSPrice Monitoring Extension
2nd Aug 20217:00 amRNSDirectorate Change
2nd Aug 20217:00 amRNSHalf-year Report
22nd Jun 202110:42 amRNSHolding(s) in Company
22nd Jun 20218:00 amRNSDirectorate Change
21st Jun 20211:03 pmRNSHolding(s) in Company
11th Jun 20214:01 pmRNSHolding(s) in Company
3rd Jun 20211:14 pmRNSHolding(s) in Company
3rd Jun 202111:26 amRNSHolding(s) in Company
2nd Jun 202110:21 amRNSHolding(s) in Company
1st Jun 20218:58 amRNSHolding(s) in Company
19th May 20212:25 pmRNSDirector/PDMR Shareholding
19th May 202111:52 amRNSResult of AGM
19th May 20217:00 amRNSTrading Statement
7th May 202111:00 amRNSTotal Voting Rights
16th Apr 20213:25 pmRNSNotice of AGM
13th Apr 20214:40 pmRNSSecond Price Monitoring Extn
13th Apr 20214:35 pmRNSPrice Monitoring Extension
13th Apr 20214:17 pmRNSDirector/PDMR Shareholding
12th Apr 20211:43 pmRNSDirectorate Change
9th Apr 20213:37 pmRNSDirector/PDMR Shareholding
6th Apr 20212:52 pmRNSBlock listing Interim Review
31st Mar 20211:38 pmRNSAnnual Financial Report
30th Mar 20217:00 amRNSFinal Results
20th Jan 20211:02 pmRNSHolding(s) in Company
30th Dec 20204:41 pmRNSSecond Price Monitoring Extn
30th Dec 20204:35 pmRNSPrice Monitoring Extension
9th Dec 20207:00 amRNSTrading Statement
7th Oct 202010:25 amRNSHolding(s) in Company
2nd Oct 202011:11 amRNSConfirmation of CFO appointment
30th Sep 20209:22 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.